(Q36501282)

14 August 2017

1 reference

title

How should we analyse FDG PET studies for monitoring tumour response? (English)

1 reference

14 August 2017

Giuseppe Giaccone

3

0 references

Adriaan A Lammertsma

object named as

Adriaan A Lammertsma

series ordinal

1

0 references

Otto S Hoekstra

series ordinal

4

object named as

Otto S Hoekstra

1 reference

14 August 2017

Corneline J Hoekstra

2

1 reference

14 August 2017

publication date

1 July 2006

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

14 August 2017

published in

1 reference

14 August 2017

volume

33 Suppl 1

1 reference

14 August 2017

page(s)

16-21

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-006-0131-5

14 August 2017

exact match

0 references

cites work

Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods

1 reference

https://api.crossref.org/works/10.1007%2FS00259-006-0131-5

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-006-0131-5

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-006-0131-5

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-006-0131-5

On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies

21 January 2018

1 reference

12 December 2020

On the Origin of Cancer Cells

1 reference

12 December 2020

Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study

1 reference

12 December 2020

Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.

1 reference

12 December 2020

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

12 December 2020

Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer

1 reference

12 December 2020

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods

1 reference

12 December 2020

Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

1 reference

12 December 2020

Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods

1 reference

12 December 2020

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

1 reference

12 December 2020

Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET

1 reference

12 December 2020

Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans

1 reference

12 December 2020

Simplified measurement of deoxyglucose utilization rate

1 reference

12 December 2020

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

12 December 2020

Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000.

1 reference

12 December 2020

10.1007/S00259-006-0131-5

Identifiers

DOI

1 reference

14 August 2017

1 reference